In a report released today, Matt Hewitt from Craig-Hallum assigned a Hold rating to Science 37 (SNCE – Research Report). The company’s shares closed yesterday at $5.75.
According to TipRanks, Hewitt is a 3-star analyst with an average return of 1.9% and a 45.42% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Codexis, Schrodinger, and Ligand Pharma.
The word on The Street in general, suggests a Hold analyst consensus rating for Science 37 with a $5.75 average price target.
See the top stocks recommended by analysts >>
Based on Science 37’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $14.89 million and a GAAP net loss of $13.92 million. In comparison, last year the company earned a revenue of $16.25 million and had a GAAP net loss of $23.53 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Science 37 (SNCE) Company Description:
LifeSci Acquisition II Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
Read More on SNCE:
